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Breast cancer (BC) is a significant health problem for New Zealand (NZ) women, with 
approximately 3,300 women diagnosed every year. Psychosocial distress is commonly 
associated with a BC diagnosis; 20-50% of women with BC will suffer from psychological 
distress within the first year after diagnosis. Distress is associated with less adherence to 
treatment; exacerbated preexisting psychological and psychiatric conditions; slower recovery 
from surgery and other treatment; and poor Quality of Life (QOL) and well-being. To treat 
distress, the Cancer Society of New Zealand, a local organisation that helps cancer patients, 
delivers a psychoeducational intervention called the Living Well (LW) programme. This 
programme deals with emotions, relaxation, perceptions, coping, self-care, and informs 
patients about their cancer, treatment and what to expect. Very little research has been done in 
NZ to assess the effectiveness of such programmes. To evaluate the effectiveness of the LW 
programme for individual BC patients, a repeated measures design was used to investigate the 
effect of the programme as measured by the Hospital Anxiety and Depression Scale (HADS), 
a screening tool commonly used to identify anxiety and depression in BC patients. 
Stage I-II BC patients referred to the Cancer Society and enrolled in the LW programme 
were recruited for the study. HADS scores were collected and analysed weekly using a repeated 
measures design prior to, during and after the intervention (LW programme).  
Analysis shows that the participants reacted similarly to the LW programme, as 
demonstrated by their HADS scores. Across all phases of the study (baseline, intervention and 
post-intervention) mean depression scores were lower than anxiety scores. During baseline 
mean anxiety scores were slightly higher, on average, than the intervention and post-
intervention phases.  
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While no consistent systematic effect on well-being from attending the LW programme 
was found, psychosocial distress in the breast cancer patients recruited for the study was 
evident. Therefore, there is value and benefit to provide interventions, to aid women by 
providing information so that they are better informed, can develop improved coping strategies, 
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Chapter One: Introduction 
Cancer is a global disease, with an estimated one in six deaths attributed to it 
worldwide (World Health Organization, 2018). Cancer rates are only predicted to increase in 
the future as populations age (Thakkar, McCarthy, & Villano, 2014). Breast cancer is the 
most common cancer to affect women, and a leading cause of female cancer deaths (World 
Health Organization, 2018).  
In New Zealand (NZ), nine women a day are diagnosed with breast cancer, which 
equates to approximately 3300 women diagnosed each year (Ferlay et al., 2015; Ministry of 
Health, 2018a). Although not as common, approximately 25 NZ men are diagnosed with 
breast cancer each year. In 2015, breast cancer accounted for 15% of female cancer deaths in 
NZ (Ministry of Health, 2018a) with approximately 600 deaths per year. According to the 
Ministry of Health (2018b), the risk of being diagnosed with breast cancer is less common in 
women under the age of 50 and increases with age; 70% of women diagnosed with breast 
cancer, and 80% who die from the disease are 50 years or older. The incidence rate of breast 
cancer in NZ is rising, increasing by 18% over the last decade (Ministry of Health, 2018a). 
However, over the last 20-30 years there have been significant improvements in breast cancer 
treatment, resulting in a steadily declining mortality rate (Ades, Tryfondidis, & Zardavas, 
2017). 
Breast cancer treatment and survival depends on the stage at diagnosis, the size and 
location of the tumour, and tumour characteristics. The individual’s age, general health, and 
menopausal status can additionally affect prognosis and treatment options (National Cancer 
Institute, 2019). Treatment typically consists of surgery, chemotherapy, radiotherapy, and/or 
endocrine therapy, with treatment modality or combinations of treatment dependent on stage 
of disease. Stage is based on the location, size and grade of the primary tumor, the spread of 
2 
 
the cancer to lymph nodes or other parts of the body, and whether specific biomarkers are 
present (National Cancer Institute, 2019). Early stage breast cancer (stage I-II) is confined to 
the breast with or without regional lymph node involvement, while late stage breast cancer 
(stage IV) indicates that the cancer has grown and has spread beyond the breast and nearby 
lymph nodes to additional organs in the body (Shulman & Torode, 2014). For women 
diagnosed with early stage breast cancer, early detection and treatment improves prognosis 
and long-term survival (Shulman & Torode, 2014).  
Non-invasive (stage 0) and early stage breast cancer have a better prognosis and 
higher overall survival rates than later stage cancers, with early stage breast cancer having a 
5-year survival rate of between 90-100% (Weiss et al., 2018). Early stage breast cancer is 
highly treatable, however it does require immediate treatment which typically consists of 
surgery, frequently followed by radiation. When breast cancer metastasises in its later stages 
eliminating tumours becomes increasingly challenging and can have a significant effect on 
the survival rate (National Cancer Institute, 2019). Typically, the later the stage the more 
treatment that is likely to be needed (American Cancer Society, 2019).   
Impact of Cancer 
Despite relatively good outcomes, a significant number of NZ women still die from 
breast cancer or suffer from recurrent disease. The psychological impact of cancer is 
becoming increasingly important and is now recognised by the NZ Ministry of Health Breast 
Cancer Guidelines (Ministry of Health, 2009). A cancer diagnosis can significantly impact 
well-being, both for the patient and the immediate family. Well-being is a multi-dimensional 
concept, with general psychological well-being typically being a broad and complex term that 
is unlikely to ever be completely captured or measured (Kvalsvig, 2018). Psychological well-
being incorporates a combination of functioning effectively and feeling good (Huppert, 
3 
 
2009). Psychological well-being also encompasses negative aspects of quality of life 
associated with psychological morbidity, such as anxiety, depression and emotional distress, 
and positive aspects that include morale, life satisfaction, self-esteem, a sense of rationality 
and happiness (Abu-Helalah, Al-Hanaqta, Alshraideh, Abdulbaqi, & Hijazeen, 2014; 
Bowling, 1991). Stable psychological well-being occurs when individuals have the 
psychological, physical and social tools that they require to adequately manage and deal with 
specific challenges (Dodge, Daly, Huyton, & Sanders, 2012). Therefore, when individuals 
face challenges for which they do not have adequate resources for, well-being is negatively 
impacted. When negative emotions are severe or long-lasting and interfere with an 
individual’s ability to function in their daily life, stress results and psychological well-being 
becomes compromised (Huppert, 2009). Psychological distress and well-being, although 
clearly distinct, are negatively associated with one another (Massé et al., 1998; Veit & Ware, 
1983). 
The National Comprehensive Cancer Network (NCCN) defines distress as “a 
multifactorial unpleasant emotional experience of a psychological, social, and/or spiritual 
nature that may interfere with the ability to cope effectively with cancer, its physical 
symptoms, and its treatment” (Holland et al., 2013, p. 192). The term distress is often utilised 
as it encapsulates psychological well-being and a wide range of psychological issues in 
addition to including cancer-specific concerns and more generalised symptoms of worry, 
fatigue, and fear (Holland et al., 2013; Park, Chun, Jung, & Hyoung Bae, 2017). Furthermore, 
the word ‘distress’ is commonly recognised as a less stigmatising term than other 
psychological or psychiatric terminology such as anxiety and depression, and is now 
becoming more acceptable to oncologists and cancer patients (Institute of Medicine and 
National Research Council, 2004; Larouche & Edgar, 2004).  
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Distress extends along a continuum, extending from common feelings of dejection, 
vulnerability, and worry to difficulties that can become disabling, such as depression and 
anxiety. For cancer patients, distress can occur at any point along the cancer continuum, from 
initial diagnosis to treatment and beyond, with the level of distress varying among individual 
patients. Specific to breast cancer, distress can occur irrespective of treatment type (Lim, 
Devi, & Ang, 2011). Many patients with newly diagnosed and recurrent cancer show 
particularly high levels of distress (Holland et al., 2013). A breast cancer diagnosis and 
treatment can have significant long-term impacts on an individual’s life, including their 
physical, functional, spiritual, emotional, and social well-being, in addition to impacting their 
psychological adjustment and distress (Park et al., 2017). Furthermore, it is important to 
recognise that although many patients’ psychological distress tends to improve over time, 
many patients still suffer from negative emotions and physical side effects even after 
treatment has ended (Cook et al., 2015). Around 20 to 50% of women with breast cancer 
suffer from psychological distress at some stage in their cancer journey, especially in the first 
year after diagnosis (Bidstrup et al., 2015; Park et al., 2017). Previous studies have reported 
that one in seven women with breast cancer experience chronic distress from their diagnosis 
alone (Helgeson, Snyder, & Seltman, 2004; Henselmans et al., 2010; Lam et al., 2010). The 
identification of distress in breast cancer patients has become more challenging as cancer care 
has become hurried and pressurised (Lang-Rollin & Berberich, 2018). 
Certain risk factors can increase the likelihood of experiencing distress and poor well-
being. These include being female, being of young age, having poor social support, marital 
status, financial situation, employment status, whether or not there is a history of 
psychological distress or other serious comorbid (additional) disorders, and physical factors 
(Agarwal et al., 2013; Enns et al., 2013; Ganz et al., 1993; Jemal, Thomas, Murray, & Thun, 
2002; Holland et al., 2013; Leedham & Ganz, 1999; Maunsell, Brisson, & Deschenes, 1992, 
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1995; Park et al., 2017; Schag et al., 1993; Schimozuma, Ganz, Petersen, & Hirji, 1999; 
Schover, 1994; Wenzel et al., 1999). Further risk factors also include treatment (Pehlivan, 
Ovayolu, Ovayolu, Sevinc, & Camci, 2012; Tan & Karabulutlu, 2005; Yavuzsen, Karadibak, 
Cehreli, & Dirioz, 2012), the stage of cancer, and the dose and length of treatment (Bultz & 
Johansen, 2011; Enns et al., 2013; Lam et al., 2010; Park et al., 2017; Runowicz et al., 2016). 
Women with chronic distress often hold a pessimistic view which may influence the adoption 
of ineffective coping strategies when dealing with their cancer diagnosis and adherence to 
treatment (Lam, Shing, Bonanno, Mancini, & Fielding, 2012; Carver et al., 1993); indeed, 
distress is one risk factor for nonadherence to treatment in women with primary breast cancer 
(Partridge, Wang, Winer & Avorn, 2003). 
Age is an important factor concerning distress and breast cancer. Premature 
menopause, amenorrhea (the abnormal absence of menstruation), and hormonal changes 
related with breast cancer treatment can be associated with cognitive impairment and mood 
disorders, and can be devastating for young women if they are faced with fertility decisions 
as a result of treatment (Warga, 2000). For some younger breast cancer patients, their 
diagnosis may also be their first encounter with the health-care system other than minor 
health conditions or childbirth, which can cause heightened anxiety (Institute of Medicine 
and National Research Council, 2004). Vickberg (2003) found that younger women had 
greater fears regarding the possibility of disease recurrence, as well as being possibly more 
susceptible to negative effects of their diagnosis and treatment, such as potential infertility, 
higher expectations about physical appearance, fatigue, poor sexual functioning, and acute 
toxicities of radiation and chemotherapy treatments (Akel et al., 2017; Al- Sulaiman et al., 
2018). Additionally, increased anxiety in younger patients can be a result of more aggressive 
disease and the expectation to return to premorbid functioning, which is defined as an 
individual’s cognitive functioning prior to a trauma or disease (Hamer et al., 2017; Sariego, 
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2010). Younger women who do not have a partner or spouse may have more anxiety around 
attractiveness, reproduction, and future intimate relationships following a breast cancer 
diagnosis and treatment such as mastectomy (Schover et al., 1995). Issues such as sexual 
dysfunction are often not acknowledged by the cancer care team, with the majority of breast 
cancer patients receiving minimal or no aid in dealing with the adverse effects that breast 
cancer and its treatment have on sexual intimacy (McKee & Schover, 2001) or biological 
changes (fatigue and hormonal changes). Physical factors contribute not only to poor well-
being, but to increased psychological distress in younger women and greater distress for their 
husbands and family (Bloom & Kessler, 1994; Northouse, 1994).  
Social support is another important factor that can either mitigate or exacerbate 
distress. Social support includes emotional or practical support, such as preparation of meals, 
assistance with daily functioning, and aid in transportation (Adler & Page, 2008) and marital 
status and can predict psychological co-morbidity amongst breast cancer patients (Abu-
Helalah et al., 2014). For example, Karakoyun-Celik et al., (2010) found that breast cancer 
patients who were unaccompanied in their medical appointments had higher levels of anxiety 
and depression. The association between marital status and distress in breast cancer patients 
is unclear. Marital status, particularly not being married or in a relationship, can be a risk 
factor for psychosocial distress (Al-Sulaiman et al., 2018), while being married can provide a 
level of social and emotional support and thereby mitigate distress (Peled, Carmil, Siboni-
Samocha, & Shoham-Vardi, 2008; Srivastava et al., 2016). Studies have found that married 
women felt more supported and protected by their husbands, and therefore were less 
psychologically distressed in comparison to single women (Peled et al., 2008; Srivastava et 
al., 2016). However, this may be subjective and dependent on the quality of the marriage or 
relationship. Finance has been identified as another predictor of psychological well-being (Ell 
et al., 2005; Hopwood, Haviland, Mills, Sumo, & Bliss, 2007; Jassim & Whitford, 2013; 
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Montazeri, Vahdaninia, Ebrahimi, & Jarvandi, 2003), with patients of low income typically 
being at an increased risk for having psychological distress secondary to breast cancer 
(Dastan & Buzlu, 2011). Villar et al. (2017) found that after treatment, breast cancer patient’s 
anxiety was most common in those who were not in active work, which includes being a 
homemaker, having time off, or being unemployed.  
Further psychological stressors that can exacerbate distress include fear and 
apprehension about death and disease recurrence, sexuality and attractiveness concerns 
related to altered body image, adjustments to femininity, and treatment-related anxiety 
(Baucom, Porter, Kirby, Gremore, & Francis, 2006; Henselmans et al., 2010; Paterson, 
Lengacher, Donovan, Kip, & Tofthagen, 2016; Reich, Lesur, & Perdrizet-Chevallier, 2008; 
Spiegel, 1997; Vahdaninia, Omidvari, & Montazeri, 2010). Additionally, breast cancer 
patients who are anxious may have a pessimistic and negative view regarding their health 
conditions and cancer prognosis, therefore, may be more inclined to be highly distressed 
(Park et al., 2017). Furthermore, distress related to a new breast cancer diagnosis and its 
treatment can also exacerbate preexisting psychological and psychiatric conditions such as 
depression, anxiety, severe stress disorder, and adjustment disorders. Breast cancer patients 
may experience behavioural and emotional changes during diagnosis and treatment (Conley, 
Bishop, & Andersen, 2016). If untreated, the psychological impact of breast cancer can have 
a detrimental impact on therapy and treatment adherence; influence the biological 
progression of the cancer; adversely affect well-being, quality of life and functioning; and can 
result in increased mortality and morbidity (Adler & Page, 2008; Al-Sulaiman et al., 2018; 
Conley et al., 2016; Martinez & Pasha, 2017; Nakatani et al., 2013). More severe 
psychological distress can also occur in the form of anxiety and depression, with breast 
cancer patients having the highest rates of anxiety and depression compared to patients with 
other types of cancer (Mehnert et al., 2014). Research suggests that nearly 50% of patients 
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had at least one episode of depression, anxiety, or both following their breast cancer 
diagnosis (Burgess et al., 2005), with anxiety generally more common than depression in 
breast cancer patients (Abu-Helalah et al., 2014; Payne, Hoffman, Theodoulou, Doisk, & 
Massie, 1999; Yi & Syrjala, 2017). Depression, although often misdiagnosed and 
undertreated among breast cancer patients, can affect between 20% to 30% of early stage 
breast cancer patients, which rises to more than 50% for those with advanced and palliative 
disease (Fallowfield, Hall, Maguire, & Baum, 1990; Fulton, 1997; Zabora, BrintzanhofeSzoc, 
Curbow, Hooker, & Piantadosi, 2001).  
In addition to psychological and social support factors, physical factors, such as 
fatigue, pain, and disrupted sleep can also influence breast cancer patient’s distress and well-
being (Institute of Medicine and National Research Council, 2004). Fatigue is one of the most 
common adverse effects of breast cancer treatment and causes substantial impairment in 
social, emotional, and occupational functioning (Wagner & Cella, 2004). Studies 
investigating the prevalence of fatigue among breast cancer patients found that up to 99% of 
patients experienced some degree of fatigue during radiotherapy and/or chemotherapy, with 
more than 60% suffering moderate to severe fatigue (Bower et al., 2000, 2006). Breast cancer 
patients with two or more comorbid conditions, including pulmonary and cardiac conditions, 
may have increased levels of distress post-diagnosis compared to those without comorbid 
conditions (Ganz et al., 1993; Lo-Fo-Wong et al., 2016). Additionally, physical recovery 
following breast cancer surgery may be impaired in individuals with psychological 
comorbidities and this may be partly responsible for an increase in psychological distress 
(Institute of Medicine and National Research Council, 2004).  
Depressive symptoms can occur on a spectrum from mild to severe and are 
challenging to evaluate for clinicians. Moreover, medical professionals, particularly 
oncologists, may be unfamiliar with screening for depression, which may lead to breast 
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cancer patients who are suffering from depression being overlooked (Greenberg, 2004). The 
incidence of depression seems to be contingent on factors including level of patient disability 
and physical impairment, pain, disease severity, and past history of depression (Aapro & 
Cull, 1999; Hopwood et al., 2007; Lansky et al., 1985; Massie & Holland, 1990; Reich et al., 
2008). During breast cancer consultations between medical professionals and family, 
discussion about life expectancy and survival, treatment outcomes on quality of life, and 
using the word ‘cancer’, which for many patients is a term synonymous with death, are 
factors which may increase depression and anxiety (Dowsett et al., 2000; Reich et al., 2008).  
Depression also impacts on treatments such as surgery and outcomes following 
treatment. Studies have compared psychological disorders, including depression, in women 
with breast cancer who undergo different surgical procedures, including mastectomy and 
lumpectomy. Goldberg, Scott, and Davidson (1992) found a significantly greater prevalence 
of depression in women who were scheduled for breast surgery compared to women who 
were found to have benign disease at the time of breast biopsy. Furthermore, women treated 
with a mastectomy may suffer depression more than women who are treated by conservative 
surgery such as a lumpectomy. Hjerl et al. (2003), who analysed early and late stage breast 
cancer patients, found that depression was a negative prognostic factor after breast cancer and 
identified a link between depression and a moderate but significantly increased risk of 
mortality, dependent on stage of cancer and time of depression. Cancer induced or long-term 
depression had no significant effect for early or late stage breast cancer patients and there was 
no statistically significant difference identified between early- and late-stage patients. 
However, postoperative depression was found to increase mortality in early stage breast 
cancer, although the effect was nonsignificant for late-stage patients. Watson, Haviland, 
Greer, Davidson, and Bliss (1999) linked depressive symptoms to a significantly reduced 
chance of survival at five years follow up for early stage breast cancer patients. Furthermore, 
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breast cancer survivors report a higher prevalence of mild to moderate depression with a 
reduced quality of life in all domains of life except for family functioning (Weitzner, Meyers, 
Stuebing, & Saleeba, 1997). Thus, treatment of depression in women with breast cancer is 
likely to increase longevity and improve coping strategies and quality of life. Diagnosis, 
surgery and recurrence of breast cancer are crucial factors to consider when assessing 
depression in order to prevent the development of psychiatric disorders (Okamura, 
Yamawaki, Akechi, Taniquchi, & Uchitomi, 2005).  It is crucial to include interventions that 
aid the psychological well-being of breast cancer patients alongside their treatment. 
Psychological Interventions 
With the prevalence of cancer-related psychological distress, identifying the 
psychological status of breast cancer patients is a crucial consideration. However, the 
psychological needs of breast cancer patients are largely overlooked. Traditionally, in routine 
clinical practice, stigma related to psychological and psychiatric needs, time constraints, poor 
understanding of psychological needs by the oncology team, and a shortage of community 
resources often negatively influence the discussion of psychological issues (Fallowfield, 
Ratcliffe, Jenkins, & Saul, 2001; Holland et al., 2013). However, in NZ the needs of cancer 
patients are being addressed through the implementation of relatively new services such as 
the Cancer Psychological and Social Support Service (CPSSS) which has been funded by the 
Ministry of Health since 2016 and operates in six District Health Boards that manage cancer 
centres (Esplin, Smith, Cherrington, Boyle, & Niemi, 2018; Ministry of Health, 2017). The 
first step to treat psychological distress is to identify it. Screening tools are a useful and 
effective way to consistently identify distress and the psychosocial needs of breast cancer 
patients. Instruments that measure psychological well-being focus almost exclusively on 
straightforward psychological constructs including depression and anxiety, such as those 
measured by the Hospital Anxiety and Depression Scale (HADS).  
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Screening Instruments  
The HADS was established by Zigmond and Snaith (1983) and is a widely used, 
reliable, self-administered questionnaire that can identify minor psychiatric impairment and 
provide clinically meaningful results (Alawadi and Ohaeri, 2009; Hopwood et al., 2007; 
Mehnert and Koch, 2008). This 14-item scale, which takes between 2 to 5 minutes to 
complete, can screen for depression and anxiety and was designed for use in a medical setting 
for patients with diverse medical and chronic illnesses, including breast cancer (Abu-Helalah 
et al., 2014; Alawadi & Ohaeri, 2009; Mehnert & Koch, 2008; Osborne, Elsworth, Sprangers, 
Oort, & Hopper, 2004; Payne et al., 1999). The HADS has been used to monitor outcomes of 
breast cancer patients in various psychosocial interventions (Montazeri et al., 2001; Spiegel et 
al., 1999), and can estimate the prevalence of psychosocial distress in breast cancer patients 
(Institute of Medicine and National Research Council, 2004). Furthermore, the HADS is 
sensitive to time changes along the cancer continuum and to the assessment of responses to 
psychotherapeutic and psycho-pharmacological intervention (Petersen & Quinlivan, 2002).  
An advantage of the HADS over other scales that measure emotional functioning and 
well-being is that it provides an estimate of the clinical level of distress by implementing 
separate threshold scores for normal, borderline abnormal or abnormal levels of depression 
and anxiety (Hopwood et al., 2007). Furthermore, the HADS has the advantage of being 
concise and succinct, and avoids contamination by physical symptoms due to items not 
coinciding with somatic conditions that may be produced by cancer (Lam et al., 2012). 
Validation of the HADS has been derived from patients with cancer (Herrmann, 1997; Burton 
et al., 1995). Thus, due to the HADS good psychometric properties (Thomas, Glynne, Chait, 
& Marks, 1997) and adequate use in the breast cancer population (Abu-Helalah et al., 2014; 
Akel et al., 2017; Bellver-Perez, Peris-Juan, & Santaballa-Beltran, 2019; Watson et al., 
1991), the HADS was selected as the tool in this current study. Screening instruments such as 
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the HADS provide a method of efficiently evaluating a large number of individuals and 
consequently identifying those suffering from psychological distress, which may result in 
better utilisation of health care resources (Payne et al., 1999). Breast cancer patients who are 
increasingly anxious and depressed have higher HADS scores and are likely to be less 
functional and more symptomatic (Abu-Helalah et al., 2014; Alawadi and Ohaeri, 2009). 
While the HADS and other psychometric assessment tools can measure the presence of 
distress, the next step is to treat the distress. One method to do this is to use an intervention to 
mitigate the impact of distress and thereby improve well-being.  
Education 
Numerous breast cancer patients rely on family, friends, and their community for 
support, or find information and support on the internet. However, some women do not have 
social support built into their lives and may lack access to psychosocial services (Institute of 
Medicine and National Research Council, 2004). Therefore, one type of intervention-based 
therapy that has been developed for breast cancer patients is education. Educational 
interventions can differ in terms of their format (individual, group, and family therapy) and 
content (psychodynamic (Spiegel et al., 1999), cognitive-behavioural (Antoni et al., 2001; 
Edelman & Kidman, 2000), psychoeducational (Okamura, Fukui, Nagasaka, Koike, & 
Uchitomi, 2003), peer discussion (Helgeson, Cohen, Schulz, & Yasko, 1999, 2001), and 
support groups (Samarel, Fawcett, & Tulman, 1997). The choice of intervention is often 
associated with various factors including the type and stage of cancer, where the individual is 
on the cancer continuum (e.g. diagnosis, treatment, or post-treatment), their psychological 
and emotional state, the stigma associated with seeking psychological support, and the 
availability and financial costs of professionals. According to the Institute of Medicine and 
National Research Council (2004), while breast cancer patients may benefit from a variety of 
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psychosocial and educational interventions, such as psychoeducation, not all interventions are 
equally effective for all patients due to individual patient characteristics such as personality.  
Psychoeducational interventions, in addition to other interventions such as 
psychological and social support, counselling, and psychotherapy, address distress that can 
arise following a cancer diagnosis and treatment (Grassi, Spiegel, & Riba, 2017; 
Zimmermann, Heinrichs, & Baucom, 2007). Psychoeducational interventions provide 
information to individuals and groups regarding illness in a social and supportive interaction 
(Institute of Medicine and National Research Council, 2004), and aims to give the patient a 
sense of control whilst additionally providing the opportunity for patients to restore lost and 
perceived control (Helgeson & Cohen, 1996). Furthermore, in breast cancer patients 
psychosocial and educational interventions have been specifically established to enhance 
psychological and social adjustment to cancer; social support, coping, and quality of life; 
improve physical functioning and well-being; and decrease psychological distress (Andersen 
et al., 2004; Boesen et al., 2011; Geiger, Mullen, Sioman, Edgerton, & Petitti, 2000; Grassi et 
al., 2017; Helgeson et al., 1999, 2001; Kissane et al., 2007; Mehnert et al., 2011; Meneses et 
al., 2007; Neises, 2008; Park, Bae, Jung, & Kim, 2012; Scheier et al., 2005; Stanton et al., 
2005; Yavuzsen et al., 2012; Zimmermann et al., 2007). Intervention methods can be direct, 
such as written materials, lectures, videos, and additional media sources, as well as indirect, 
such as modelling of effective coping behaviours by group members and peer discussions.  
Typically, psychoeducational interventions will include four major themes including 
psychotherapy, education, coping, and emotional support (Okamura et al., 2003). These 
interventions often incorporate techniques such as those used in behavioural analysis, which 
has been defined as a discipline that uses scientific methods to explain relations between 
environmental inputs and behavioural outputs, then uses these relations to explain, and if 
feasible, improve the behaviour of humans and animals (Poling, 2015). These interventions 
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aim to modify behaviour to a meaningful degree and to demonstrate that the interventions 
implemented are responsible for the improvement in behaviour (Broardstock, 2011). 
Interventions may address emotions, relaxation, perceptions, coping and managing the illness 
and its side effects, self-care, and they can also inform patients about their cancer, their 
treatment and what to expect, particularly patients with inadequate information.  
One aim of psychoeducational interventions is to improve health knowledge and 
literacy, which is tailored to meet patient’s levels of literacy or education and has a critical 
impact on health outcomes (Costas et al., 2013). The knowledge of cancer patients influences 
their capability to contribute in the decision-making processes for treatment choices, 
adherence, and their ability to cope with their cancer to improve medical outcomes. Increased 
knowledge about cancer diagnosis and treatment has been identified as a key factor in the 
variation in survival (Goodwin, Samet, & Hunt, 1996). By modifying behaviour and 
providing breast cancer patients with information that is culturally appropriate and tailored to 
the patients’ needs and literacy levels, improvements can be seen in the management of 
breast cancer, compliance with treatments, and prevention of progression or relapse 
(Cummings & Cummings, 2008).  
Medical staff can be highly effective at implementing psychoeducational 
interventions for breast cancer patients, in individual or group environments, preferably 
directly after diagnosis or surgery (Zimmermann et al., 2007). Group therapy for cancer 
patients is equally, and perhaps substantially more in the instance of group psychoeducational 
interventions, effective when compared to individual therapy (Sheard & Maguire, 1999). 
Group psychoeducational interventions are generally cheaper and more cost effective than 
other therapies, and easy to implement, deliver and reproduce (Sheard & Maguire, 1999; 
Tong et al., 2019). A group format can provide patients with the opportunity to learn in a 
setting with other patients who are in similar situations, consequently alleviating the sense of 
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isolation and delivering additional social support (Adamsen & Rasmussen, 2001; Jones et al., 
2013). Group interventions can offer several benefits for patients such as improved 
information regarding disease, improved self-esteem and emotional well-being, increased 
sense of control and empowerment, social support from others in similar situations, and 
facilitation of positive relationships (Balabanovic, Ayers, & Hunter, 2012; Edelman, Bell, & 
Kidman, 1999; Ussher, Kirsten, Butow, & Sandoval, 2006). Additionally, decreases can be 
seen in cancer worry and perceived risk of disease recurrence (Cameron, Booth, Schlatter, 
Ziginskas, & Harman, 2007).  
In breast cancer patients, psychoeducation has been shown to improve quality of life 
(Chujo et al., 2005; Faller et al., 2013; Wang et al., 2017; Zimmermann et al., 2007), provide 
confidence and comfort, enhance a sense of control (Campbell, Phaneuf, & Deane, 2004; 
Helgeson et al., 2001), decrease the distress caused by the illness (Fawzy & Fawzy, 1998), 
alleviate the sense of isolation, and deliver additional social support (Adamsen & Rasmussen, 
2001; Jones et al., 2013). Additionally, patients can learn how to confront stressors with a 
positive attitude and use active behavioural strategies (Andersen, 1992). Research suggests 
that psychoeducational interventions that provide patients with adequate resources and 
information to better understand, adjust and cope with their symptoms can reduce duration, 
frequency, and intensity of breast cancer disease and treatment-related symptoms (Jones et 
al., 2013) and can assist in normalising a cancer patient’s circumstances and decrease 
uncertainties for the future by facilitating communication with others in a similar situation 
(Fawzy, Fawzy, Arndt, & Pasnau, 1995; Tong et al., 2019).  
A review by Helgeson and Cohen (1996) found clear and consistent benefits of 
psychoeducational group interventions for people with cancer. However, there was less 
evidence whether these benefits were short term or had a lasting impact, particularly in breast 
cancer patients. In a later study Helgeson et al. (1999) compared psychoeducation and peer 
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discussion group interventions in early stage breast cancer patients. The psychoeducational 
intervention focused on delivering information to patients about breast cancer and how to 
cope with the diagnosis and negative effects of treatment, with the idea to enhance the 
patient’s control over their illness. The peer discussion group, which involved facilitators 
encouraging patients to assist each other, aimed to provide emotional support through the 
expression of feelings. The study found consistent positive benefits for the psychoeducational 
intervention group immediately after and six months following the intervention. These 
benefits included enhanced body image, increased self-esteem and perceived control, 
improved discussions with peers and family, and decreased aversive thoughts and uncertainty 
regarding breast cancer. The decrease in aversive cognitions and improvements in self-esteem 
contributed the greatest to the increase in quality of life. However, no benefits were found for 
the peer discussion group. Instead greater intrusive and avoidant thoughts were found 
compared with patients who were not in the peer discussion group. The authors additionally 
proposed that information-based psychoeducational groups demonstrated greater 
improvements in regard to their physical functioning whilst emotion-focused peer discussion 
groups were effective for women who lacked support from their medical team or family 
(Helgeson, Cohen, Schulz, & Yasko, 2000). Helgeson et al. (2001) then looked at longer-
term effects of a brief 8-week intervention compared to a peer discussion group in early stage 
breast cancer patients. They found that some of the benefits such as higher levels of energy, 
decreased physical pain and improved physical functioning and quality of life remained over 
a three-year timeframe. It was suggested that these results may be a consequence of the 
patients in the psychoeducational intervention obtaining information, such as information 
associated to well-being, nutrition and exercise, that they were able to use immediately and in 
the long-term to ease daily functioning. Therefore, it was concluded that there are well-
defined and consistent benefits of a brief psychoeducational intervention for early stage 
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breast cancer patients, with some effects remaining long-term. Long term benefits were 
additionally found by Jones et al. (2013). Jones et al., (2013) compared breast cancer patients 
who received standard print material (usual care) to breast cancer patients who received 
standard print material (usual care) in addition to attending a two-hour single session group 
psychoeducational intervention designed for breast cancer patients. Six months after the 
intervention patients who had attended the intervention demonstrated persistent increased 
knowledge concerning their illness and its after-effects and enhanced preparedness to 
transition into the recovery phase. Moreover, Edelman, Craig and Kidman (2000) reviewed 
the evidence for the efficacy of “supportive” compared to “psychoeducational” approaches in 
cancer patients. Supportive groups focus on the expression of emotions and the development 
of social support and emphasise discussion and expression of feelings and emotions. 
Psychoeducational groups encourage various coping skills such as goal setting, problem-
solving and relaxation. The authors found that the majority of evidence suggests that cancer 
patients, including those with breast cancer, experience greater benefits from attending 
psychoeducational groups rather than supportive groups.  
Studies have also specifically demonstrated the benefits of psychoeducational 
interventions on the well-being of breast cancer patients. Ram, Narayanasamy, and Barua 
(2013) focused on the impact of group psychoeducation that was completed over 4-weeks.  
The intervention emphasised the delivery of medical information and the causes of cancer, 
prognosis and treatment strategies. The authors concluded that the intervention played a 
crucial role in improving well-being and decreasing depression. Al-Sulaiman et al. (2018) 
used six 60- to 90- minute psychoeducational-based interventions over 12-weeks, for women 
with early stage breast cancer. Participants were randomised into either a psychoeducational 
intervention, a crisis counselling group, or a control group. The intervention consisted of four 
core components: coping and problem-solving guidance, stress management and behavioural 
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training, health education, and psychological support. It was found that the intervention was 
effective in improving psychological well-being and quality of life at 18-months follow-up. It 
was also found that 95% of patients in the study were compliant with treatment. This study 
also demonstrated that psychoeducation had a larger advantage over counselling, particularly 
in improving patient’s well-being. The significant improvements found in the psychological 
well-being of patients in both intervention groups (counselling and psychoeducation) were 
suggested to be a result of patients having the opportunity to express their concerns and 
emotions in addition to learning various coping mechanisms to deal with their illness. 
Doulbeaut et al. (2009) evaluated the effectiveness of an 8-week psychoeducational 
intervention after early-stage breast cancer treatment. The intervention consisted of 2-hour 
sessions involving thematic conversations and education in stress management strategies. The 
intervention was found to be effective, and reduced negative moods/emotions, such as 
anxiety, depression and fatigue, and improved interpersonal relationships, health status, and 
role and emotional functioning. 
Maeda, Kurihara, Morishima, and Munakata (2008) investigated the effectiveness of a 
psychoeducational intervention on adaptive coping and psychological well-being in early 
stage breast cancer patients over six-months. The intervention involved three sessions 
consisting of three components: providing psychological information, delivering treatment 
information, and counselling. Five measures were utilised, which included the HADS 
(Japanese version), and took place after surgery (pre intervention), 1 month (post-
intervention) and 3 months after discharge (follow-up). HADS scores for anxiety and 
depression did not significantly differ between baseline, intervention and post-intervention 
phases and the authors found no consistent systematic effect on well-being over 6 months. 
Andreis et al. (2018) evaluated the impact of 13 psychoeducational groups in women with 
breast cancer where the intervention involved helping patients deal with the emotional, 
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physical, and lifestyle adjustments associated with cancer. Using the HADS and Body Image 
Scale (BIS), no effect on anxiety was found, but a statistical difference, thus improvement, in 
depression score at baseline and post-intervention was found. Cipolletta, Simonato, and 
Faccio, (2019) investigated the effectiveness of psychoeducational-based groups and found 
that in addition to improving well-being, a psychoeducational intervention can create 
emotional support, novel social relationships that alleviate the sense of loneliness and 
isolation, and opportunities to increase personal resources for breast cancer patients. After the 
intervention, support was also found to be a good predictor of both physical and 
psychological well-being.  
Applied Behaviour Analysis 
Another type of intervention is Applied Behaviour Analysis (ABA). ABA is a 
psychological based method which has promise for treating cancer-related psychological 
issues, however, as far as the researcher is aware, ABA has not been implemented for this 
purpose in the cancer field. ABA interventions use principles of learning theory whereby the 
theoretical foundation lies in the behavioural conditioning studies of Thorndike (1898), 
Pavlov (1927), and Skinner (1938;1953). ABA can be applied in a systematic and measurable 
approach to improve, reduce, maintain and/or generalise target behaviours (Broadstock, 
2011). Behavioural interventions can be applied to all aspects of life (Redd, Montgomery, & 
DuHamel, 2001) as human behaviour is shaped by its consequences (Baum, 2005). ABA 
work is wide-ranging, with early behavioural interventions in humans being practical, aiming 
to adjust environmental and social conditions and coping skill deficits that adversely 
influence daily performance. ABA has produced effective and influential interventions in 
fields such as education, clinical psychology, people with developmental disabilities and 
autism spectrum disorder (ASD), and behavioural medicine and medical conditions, such as 
cancer (Mundy, DuHamel, & Montgomery, 2003; Redd et al., 2001; Slocum et al., 2014). In 
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individuals with ASD or with intellectual disabilities, ABA has proven a highly effective 
intervention (Rosenwasser & Axelrod, 2001; Weiss, DelPizzo-Cheng, LaRue, & Sloman, 
2010) and can decrease inappropriate behaviour, increase communication and teach 
appropriate social behaviour and learning. Although not as common, various interventions 
have been applied to cancer patients including behavioural interventions (Mundy et al., 
2003), psychological interventions (Andersen, 1992), psychosocial interventions (Baum & 
Andersen, 2001), and exercise training interventions (Loughney, West, Kemp, Grocott, & 
Jack, 2018). Although not widely applied, there has also been significant progress made 
concerning the application of ABA to a broader range of socially significant behaviours 
including improving academic skills (Campbell & Anderson, 2011; Eckert, Ardoin, Daly, & 
Martens, 2002), health-related behaviours (Alessi, Petry, & Urso, 2008; Washington, Banna, 
& Gibson, 2014), and sport performance (Brobst & Ward, 2002; Harrison & Pyles, 2013). 
Moreover, there is potential to utilise ABA to improve health literacy and consequently 
decrease hospital mortality and morbidity rates (Lynch & Franklin, 2019). However, despite 
the existence of ABA research showing it’s potential to improve various socially significant 
problems in a variety of populations, it is not currently widely utilised used in a 
medical/health setting. Given the psychological impact of breast cancer on patients and their 
families, there is potential for these techniques to be applied to breast cancer patients through 
psychoeducation.  
Design 
One type design often used in ABA is repeated measures, which is commonly used 
because of its emphasis on the behaviour of individuals (Baer, Wolf, & Risley, 1968). The 
repeated measures design requires fewer participants and less time to conduct an experiment 
compared to that of independent measures, or group designs (Verma, 2015). All subjects take 
part in the experiment and all participants serve as their own control. Repeated measures 
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design typically use three to five subjects to investigate whether the implementation of an 
intervention leads to observable changes in a dependent variable over time (Janosky, Al-
Shboul, & Pellitieri, 1995). Each participant comprises a comprehensive basis for reasonable 
conclusions, though without evidence of generality to other individuals (Johnston & 
Pennypacker, 2009). Information concerning generality comes from looking at the results of 
individuals together and by replication with individuals from other populations. The common 
purpose of repeated measures designs, such as reversal designs and multiple-baseline designs, 
is to demonstrate experimentally the extent to which the effects of manipulating aspects of 
the environment reliably result in behavioural change. Thus, this design controls factors that 
cause variability between participants, advises how participants respond to treatment, and 
allows for repeated measures at baseline and post-intervention. The success of the 
intervention could be determined through individual characteristics, therefore there is no need 
for group percentages (Butler, Sargisson, & Elliffe, 2011). It is beneficial for researchers to 
be aware of a repeated measures design as few participants are required to be recruited and 
the design can be a cost-effective and time adequate option, especially with small samples. 
Limited research has used a repeated measures design to investigate the effects of an 
intervention on well-being in breast cancer patients, however, in small numbers of breast 
cancer patients repeated measures designs have been shown to effectively demonstrate the 
effects of other health interventions, such as a Pilates intervention (Keays, Harris, Lucyshyn, 
& Maclntyre, 2008), an upper extremity resistance exercise programme (Sander, 2008), and 
cognitive-behavioural therapy (CBT) (Quesnel, Savard, Simard, Ivers, & Morin, 2003). 
There is a small amount of studies which have used repeated measures designs in 
participants with other cancer types. A repeated measures AB design (two part design 
composed of “A” baseline and a “B” intervention phase) was used to evaluate an acceptance-
based intervention for children and adolescents with cancer who were experiencing pain 
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despite having received pharmacological intervention (Cederberg, Dahl, von Essen, & 
Ljungman, 2017). The acceptance-based intervention, which was delivered in addition to the 
standard pain management, involved a 15-minute pain exposure exercise comprising 
instructions on how to practice attentive focus, such as awareness of their cognitions, 
feelings, and bodily sensations, whilst simultaneously acknowledging the pain stimuli. The 
intervention was found to help all five of the participants to cope with the pain in the moment 
and to decrease discomfort of pain at follow-up. Three participants also reported decreased 
pain intensity. Gershon, Zimand, Lemos, Rothbaum, and Hodges (2003) investigated the use 
of virtual reality as a distractor to alleviate pain and anxiety in a pediatric cancer patient using 
an A-B-C-A repeated measures design. The design involved four consecutive appointments 
comparing no distraction (A), non-virtual reality distraction on a computer screen (B), and 
virtual reality distraction with a headset (C). The study found value for using virtual reality as 
a distractor during painful medical processes which was demonstrated by the decrease in pain 
and anxiety ratings, fewer identified behavioural indicators of distress, and reduced 
physiological arousal. The authors also proposed that following the virtual reality condition, 
benefits of decreased anxiety, pain and pulse rate were sustained even when the virtual reality 
was not in use. A further study used a repeated measures design (A1BA2), involving a 
baseline phase, an intervention phase and a back to baseline phase, to investigate the 
effectiveness of an internet intervention on nine patients with a diagnosis of prostate cancer 
(Kazer, Bailey Jr, Sanda, & Kelly, 2011). The study aimed to teach men how to reassess their 
perspectives on prostate cancer and provided tools for self-care management. They found 
trends that indicated a positive impact of the intervention on quality of life. These studies 
demonstrate the usefulness and potential of repeated measures design to assess the 
effectiveness of interventions in the cancer population. 
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The NZ Ministry of Health recognises that psychosocial support is an essential 
component of quality supportive cancer care and to aid in alleviating distress associated with 
cancer (Ministry of Health, 2010, 2017). As a result, the Ministry of Health funded the 
CPSSS (Esplin et al., 2018; Ministry of Health, 2017) which focuses on delivering emotional, 
social and psychological support to people and their families whose cancer has had a large 
impact on their life from early diagnosis through to the end of treatment. The service aims to 
improve consistency in regard to access and service delivery, with particular focus on patients 
with complex psychological and social needs related to their diagnosis, Māori and Pacific 
communities, remote and rural populations, and people with socio-economic disadvantage 
(Esplin et al., 2018). Although psychosocial support needs and services in NZ have not been 
greatly evaluated and assessed, a preliminary evaluation of the CPSSS service has found it to 
be vastly beneficial and valuable to patients and their families in regard to overall health and 
well-being and adherence to treatment (Esplin et al., 2018). Additionally, patients and their 
families have acknowledged the benefits of various psychological strategies which were 
provided to them by the service, such as the management of panic attacks, managing life 
during treatment, transport assistance, and income support.  
The Cancer Society of New Zealand and New Zealand Guidelines Group suggest that 
cancer patients can experience enhanced quality of life and decreased distress when receiving 
adequate psychological, social and cultural support (Ministry of Health, 2017). In NZ, 
specific support and education groups, such as the Living Well (LW) programme and the 
Look Good Feel Better workshop, delivered by the Cancer Society, aid women affected by a 
breast cancer diagnosis. The Look Good Feel Better workshop has been shown to benefit 
women with low self-esteem and poor body image by increasing social interaction and self-
image and diminishing anxiety (Taggart, Ozolins, Hardie, & Nyhof-Young, 2009). The LW 
programme is a psychoeducational-based group intervention also run by the Cancer Society 
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in NZ. The LW programme is a design similar to the Cancer to Health Program which is a 
psychoeducational intervention designed in the early 2000s at Ohio State University for 
cancer patients. The Cancer to Health Program aimed to change patient behaviour; teach 
patients to become physically active, methods to reduce their distress and how to seek social 
support; strategies to improve well-being, quality of life, and mood; and ways to 
communicate with their treatment team (Ohio State University, 2018). Andersen et al. 
(2010)., who designed the programme, found that breast cancer patients who participated in 
the program had notably improved health, mood and immune responses, and a decreased risk 
of breast cancer recurrence. The LW programme is one of several established programmes 
offered by the Cancer Society approximately three to four times a year. The programme is 
administered at the Cancer Society Lodge in Hamilton, NZ, by specially trained liaison 
nurses with the addition of expert speakers from a variety of backgrounds and professions. 
The LW programme consists of two 4-5 hour sessions over a 2-week period (i.e. two 
sessions), and typically involves 15-35 participants. The aim of the LW programme is to 
assist women to cope with cancer-related treatment side-effects to improve their quality of 
life, well-being, body image, and self-esteem by providing them with adequate information 
regarding what to expect and how to manage their cancer journey. The sessions offer 
participants of any stage and type of cancer practical ways of living well, building 
knowledge, and provides tools to increase self-confidence and self-help skills.  
Summary, Aim and Hypotheses for the Present Study  
The present study aimed to assess the effects of the Living Well (LW) programme on 
the psychological well-being of breast cancer patients in the Waikato region. The study used 
a repeated measures design which involved baseline, intervention, and post-intervention 
phases (A1BA2).  
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Data was obtained via completion of the HADS questionnaire each week for four 
weeks before the intervention (the LW programme) began, two weeks during the intervention 
phase (which involved participants attending the LW programme), and four weeks post-
intervention. Results were analysed by comparing the HADS scores collected during 
baseline, intervention and post-intervention phases. The HADS was administered to each 
participant at least nine times so that an overall understanding of the participant’s 
psychological distress could be confidently obtained, and researchers could determine 
whether participation in the LW programme mitigated these feelings in any way.  
It was hypothesised that the psychoeducational intervention (the LW programme) 
would improve well-being in breast cancer patients, as measured by a decrease in HADS 





Chapter Two: Method 
Subjects 
Breast cancer patients referred to the Cancer Society between the 15th of May and the 
20th of August 2019 were invited to participate in this study. Ethical approval for this study 
was obtained from the Human Research Ethics Committee (Health) of the University of 
Waikato under HREC(Health) 2019#43. Approval to recruit participants from the Cancer 
Society was also obtained from the Chief Executive from the Waikato Bay of Plenty Division 
of the Cancer Society. 
The participants included six females, all with a diagnosis of breast cancer (mean age: 
56 years; age range: 41-73 years) and all residing in the Waikato region. Participant 
characteristics are shown in Table 1. 
Table 1       
        
Demographic Profile of Participants      
ID  Ethnicity Locality  Stage Referral  Marital status Employment  Age 
1 Other Urban Diagnosis Self-
referred 
Married Self-employed 58 
2 NZE Urban Treatment CNS  Married Retired 73 
3 Other Rural Treatment CNS  Married Unemployed 41 
4 NZE Urban Post-
treatment 
BCC Married Full-time  56 
5 NZE Urban Diagnosis CNS  Married Other 61 
6 NZE Urban Treatment CNS  Separated Benefit 47 
Note. NZE = New Zealand European; CNS = Cancer Nurse Specialist; BCC = Breast Care Centre 
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The Hospital Anxiety and Depression Scale (HADS) was administered each week by 
the researcher to each participant at an agreed upon location. However, the participants who 
were unable to meet the researcher directly during the baseline phase (weeks 1-4) completed 
the HADS form via a phone call each week. Whichever method was used during baseline was 
consistently used throughout the rest of the study for each participant. For example, if a 
participant initially completed the HADS in person, subsequent HADS scores were also 
collected in person (and likewise if via telephone).  
In accordance with the Cancer Society protocol, the Living Well (LW) programme is 
presented in a format that meets the specific needs of the group of patients enrolled at one 
particular time. Table 2 shows the topics that were covered in the first session of the 




Hamilton Living Well Programme 2019- Session 1  
Presenter Topics 
Cancer Society Nurse Meet and Greet 
Oncologist A new normal; Understanding the cancer experience;  
What is cancer 
Dietician Eating healthy through your cancer journey 
Physiotherapist Lymphoedema and PINCnSteel 
Supportive care nurse Debunking myths 
 Cancer Society Nurse Wrap up and evaluation  
Note. PINCnSteel = PINC and Steel Cancer Rehabilitation Program 
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Table 3   
Hamilton Living Well Programme 2019- Session 2  
Presenter Topics 
Cancer Society Nurse Meet and Greet 
Employee from HQSC NZ Advanced Care Plan 
Counsellor Cancer and uncertainty 
Sport Waikato  Healthy movement and exercise 
Clinical psychologist Managing cancer related fatigue 
Cancer Society Nurse Wrap up and evaluation  
Note. HQSC = Health Quality & Safety Commission 
Materials 
Demographic Questionnaire. Demographic information was obtained via a self-
report form prior to the commencement of the study (see Appendix A). The information 
collected included age; gender; contact details of the participant; ethnicity; the area in which 
the participant resided in; date of cancer diagnosis; any previous cancer diagnosis; stage on 
the cancer continuum; date of referral to the Cancer Society and by whom; any previous 
psychological, psychiatric or counselling services since diagnosis; participation in any 
previous Cancer Society programmes; family support; marital status; employment status; 
accessed resources regarding cancer since diagnosis; and day and time that was suitable to be 
contacted by the researcher.  
Participant information sheet. A Participant Information Sheet (see Appendix B) 
was provided to participants which explained: the purpose of the study, what participation in 
the study would involve, the possible benefits and risks of the study, each participant’s rights 
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and instructions on what to do if participants changed their mind and no longer wanted to 
participate in the study, and the contact information of the researcher, the researcher’s 
supervisor and the cancer liaison nurse (from the Cancer Society).  
Consent form. Participants were given two consent forms for the study. The consent 
form stated that the participant had been given the Participant Information Sheet, that they 
had been given the opportunity to ask any questions, and had been informed that they could 
withdraw at any time from the study. All participants signed one copy of the consent form, 
which was retained by the researcher (see Appendix C).  
Confidentiality was ensured by assigning a study ID (1-6) to all participants. In addition, 
all data was stored electronically in password protected files on the University of Waikato 
servers. Data will be stored for 5 years, which is the standard University of Waikato data 
storage period. No information that could personally identify participants was used.  
HADS. In addition to the demographic questionnaire completed at the start of the 
study, participants completed the HADS at several time points throughout the study. The 
HADS require each participant to evaluate and report on the severity of any anxious or 
depressive symptoms felt in the previous week. Responses to each item are quantified on a 
four-point Likert scale, ranging from 0 to 3.  The scoring of each subscale can range from 0 
to 21, with higher scores indicating higher levels of anxiety and depression (Zigmond & 
Snaith, 1983).The subscales for anxiety and depression are interpreted separately using the 
following ranges: normal (0-7), mild (8-10), moderate (11-14), and severe (15-21). For both 
the anxiety and depression subscale a score of 0 to 7 is classified as normal, a score of 8 to 10 
suggests borderline depressive or anxiety disorder, and a score of 11 or higher is indicative of 
possible clinically significant levels of anxiety and depression according to recommended 
thresholds (Hopwood, Howell, & Maguire, 1991; Zigmond & Snaith, 1983).  
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The reliability and validity of the HADS has been established for cancer patients 
(Bidstrup et al., 2015; Moorey et al., 1991). It has good internal consistency (Cronbach’s 
alpha 0.76-0.93 and 0.81-0.90 for the anxiety and depression subscales respectively, and 0.87 
for the general scale) (Montazeri et al., 2003; Petersen & Quinlivan, 2002; Villoria & Lara, 
2018), and test-retest reliability shows a high correlation, r>0.80, after up to 2 weeks, 
emphasising the stability of the HADS to withstand situational influences (Herrmann, 1997).  
Possible confounding factors independent of participation in the intervention (LW 
programme) could impact upon participant’s well-being and psychological distress and 
therefore influence results. Thus, for the purposes of this study, an additional question was 
provided at the end of the HADS for participants to complete to record these possible 
confounding variables. This additional question read as ‘Have you had changes to your 
personal circumstances, such as changes to your financial situation, marital status, working 
conditions and/or social support (you do not need to answer this question if you do not feel 
comfortable doing so)? Y / N. If yes, please specify?’ Yes/No responses were coded as 0=No, 
1=Yes. This question was designed to record any additional changes, that may, or may not 
have been cancer-related, that the participant may have experienced that week which may 
subsequently have influenced or impacted on their HADS scores (e.g. confounding 
variables).  
Scores on the HADS were considered the dependent variable and attendance at the 
LW programme was considered the independent variable. The effectiveness of the LW 
programme on participant’s well-being was measured through administering the HADS to 
participants before the LW programme began (i.e., baseline), during the LW programme (i.e., 
during the intervention) and after the LW programme (i.e., post-intervention) had been 




Experimental design. A repeated measures design was used to assess the impact of 
the intervention (the LW programme) on specific individuals, rather than groups of 
individuals. Continuous assessment was utilised, where the behaviour of each participant was 
observed repeatedly over the duration of each phase of the study (baseline, intervention, post-
intervention) so that the degree of variability in HADS scores could be determined in each 
phase and compared with any variability that was observed as the phases changed. The 
intervention was implemented after a fixed time period of three to four weeks (depending on 
when the participant began the study).  
The repeated measures design involved a reversal design (A1BA2), which involved 
alternation of the baseline (A) and intervention (B) phase: three to four weeks of observation 
(baseline phase A1) followed by two LW sessions (intervention phase B) and then another 
four weeks of observation (reversal phase A2).  
Procedure 
In accordance with the Cancer Society protocol, when participants are referred to the 
Cancer Society via self-referrals, general practitioner (GP), cancer nurse specialist (CNS), 
and other medical professionals, they receive a home visit from a cancer liaison nurse. During 
the home visit, the cancer liaison nurse establishes rapport with each patient and advises their 
family/whanau of the services that the Cancer Society offers. For the purposes of this study, 
this initial visit was used as the point of patient recruitment, where the cancer liaison nurse 
identified and approached potential patients for participation in the study and likewise 
identified any extremely vulnerable patients who were consequently not approached for 
participation. Participants who were referred through the above pathways between the 15th of 
May and the 16th of August 2019, in addition to indicating interest in the LW programme and 
meeting the inclusion criteria (below) for participation in the study, were consequently 
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assessed by the Cancer Society liaison nurse. The inclusion criteria for this study included: 
being over the age of 18 years old; being newly referred to the Cancer Society; having a stage 
1 or 2 breast cancer diagnosis; not currently participating in other Cancer Society support 
groups or having previously attended the LW programme run by the Cancer Society. 
Participants deemed suitable for the study based on the inclusion criteria (above) were 
informed that a study was being conducted by a masters’ student from the School of 
Psychology at the University of Waikato. The Cancer Society liaison nurse asked each 
participant for consent to have their contact details passed on to the researcher (master’s 
student) for further information regarding participation in the study. If those individuals who 
were approached were interested in participating in the study and gave consent for their 
details to be passed on to the researcher, they were given a Participant Information Sheet, 
consent form and demographic questionnaire form (which was completed at a later date with 
the researcher). The researcher then contacted each participant and arranged to meet them at 
an agreed upon location (except for one participant who requested to complete the Participant 
Information Sheet, consent form and demographic questionnaire form via a phone 
conversation due to their location). Meeting with each participant allowed the researcher the 
opportunity to establish rapport, explain the Participant Information Sheet, and ask the 
participant to complete the consent and demographic questionnaire forms. The researcher 
clearly outlined to participants that the decision to participate, or not participate, did not 
affect the level of care that they were due to receive from the Cancer Society or any other 
health professionals. The researcher arranged a weekly meeting with the participant at an 
agreed upon location and time in order to begin collection of baseline data each week using 
the HADS scale. However, if participants indicated that they were unable to meet directly 
with the researcher each week, the alternative process of the researcher calling the participant 
each week via the telephone and administering the HADS scale was suggested.  
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After consent had been received and prior to the commencement of the LW 
programme, baseline data was collected (in person or via a phone call) for at least three 
weeks. The intervention phase began once the collection of the baseline data was completed 
i.e., (3-4 baseline data points) and in accordance with the LW programme dates set by the 
Cancer Society (2nd of September and 9th of September). Each participant was asked to attend 
both sessions of the LW programme. The HADS form was administered each week after the 
LW session had finished in the same manner in which it was completed during the baseline 
phase (i.e., in person or via a phone call). As the LW programme consisted of two sessions, 
the HADS form was completed twice during this phase (after the first session and again after 
the second session).  
After completion of the two-week LW programme, further HADS scores were 
collected at multiple timepoints, as per the baseline phase. To achieve this, participants were 
asked to complete the HADS form once a week for four weeks after the LW programme was 
completed. For consistency of data collection, the completion of the HADS forms occurred in 
the same manner as the baseline and intervention phases of the study. At least nine HADS 
forms were completed by each participant. 
Data from baseline, intervention, and post-intervention were graphed for all 
participants and visually assessed for changes in HADS scores during baseline, intervention 
and post-intervention. Mean anxiety and depression scores from the HADS were also 
calculated for baseline, intervention and post-intervention and graphed. Visual analysis was 
used to determine the effectiveness of the LW programme and whether attendance had 
altered the participants pre-intervention HADS scores.  
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Chapter Three: Results 
Results for each participant were collected during baseline (week 1 to week 4), 
intervention (week 5 and week 6) and post-intervention (week 7 to week 10) phases (see 
Figures 1-6). The solid vertical line in the graph indicates condition changes between the 
baseline and intervention phases and the intervention and post-intervention phases. The 
dotted line with circles represents the depression scores and the solid line with squares 
represents the anxiety scores.  
For participant 1 (see Figure 1) depression scores remained low and stable in the 
range of 1 to 2 during both baseline and post-intervention. During the intervention phase, 
there was an increase in week 6 to a score of 4. However, all of these scores fell within the 
“normal” range for depression. Across all phases, anxiety scores were higher than depression 
scores. Apart from week 1, scores during baseline were fairly stable and largely within the 
“normal” range for anxiety.  Anxiety scores in the intervention phase increased from the 
“borderline abnormal” range to the “abnormal” range. During the post-intervention phase, 






Figure 1. HADS scores for participant 1 during each phase  
PME=positive cancer-related medical events; NME= negative cancer-related medical events; 
MEUC= medical events unrelated to cancer 
The depression scores for participant 2 (see Figure 2) remained low during baseline 
ranging between 1 to 7 (“normal”) except during week 2 where there was increase to 9 
(“borderline abnormal”). During the intervention and post-intervention phase, depression 
scores remained low and within the “normal” range. Anxiety scores were higher than 
depression scores and ranged between 8 to 11 (“borderline abnormal” – “abnormal”) during 
baseline, intervention and post-intervention phases except during week 2 of the baseline 


































Figure 2. HADS scores for participant 2 during each phase  
NME= negative cancer-related medical events; FC= family related 
changes 
 
Participant 3 (see Figure 3) did not complete the HADS during week 2. Depression 
scores remained low and stable ranging between 0 to 3 (“normal”) across all phases. Anxiety 
scores also remained stable and low ranging between 0 to 5 (“normal”) across baseline, 































Figure 3. HADS scores for participant 3 during each phase  
For participant 4 (see Figure 4) depression scores were relatively low with a slight 
decreasing trend to week 4 during baseline (“normal”). Scores remained low and in the 
“normal” range during intervention and post-intervention, except for week 8 where the score 
increased to 8 (“borderline abnormal”). Anxiety scores were initially higher than depression 
scores during baseline, ranging between 13 to 5 (“abnormal”- “normal”). Anxiety scores 
decreased to the “normal” range during intervention and post-intervention, however there was 





























Figure 4. HADS scores for participant 4 during each phase  
NME= negative cancer-related medical events; FC= family related changes; N-CS= non-
cancer related stress; SS= changes to social support 
 Participant 5 (see Figure 5) did not complete the HADS in week 1. Depression scores 
were slightly variable and low in baseline remaining in the “normal” range (0-7) then 
increased to 13 (“abnormal”) before decreasing back to 5 (“normal”) in the intervention 
phase. Post-intervention depression scores were stable, ranging from “normal” to “borderline 
abnormal”. Anxiety scores were higher than depression scores ranging between 10 to 19 
(“borderline abnormal” – “abnormal”) across all phases. There was a decreasing trend during 
baseline, then in intervention and post-intervention anxiety scores were slightly variable and 

































Figure 5. HADS scores for participant 5 during each phase  
NME= negative cancer-related medical events; FC= family related changes; MEUC= 
medical events unrelated to cancer 
 Depression scores for participant 6 (see Figure 6) started high (12) in week 1 but then 
remained relatively stable and ranged between 5 to 9 (“normal”- “borderline abnormal”) for 
all remaining phases. Scores for anxiety were again higher than depression scores across 
baseline, intervention and post-intervention phases. Anxiety scores decreased during baseline 
in week 4 (“abnormal”), and after a slight increase in week 5 a further decrease occurred in 
week 6 of the intervention phase to the “borderline abnormal” range. Scores for anxiety 


































Figure 6. HADS scores for participant 6 during each phase  
NME= negative cancer-related medical events; FC= family related changes; N-CS= non-
cancer related stress; SS=changes to social support 
 Figure 7 shows the mean HADS scores for depression and anxiety across all study 
phases (baseline, intervention, and post-intervention) for the six participants. Across all 
phases, mean depression scores were lower than anxiety scores and were within the “normal” 
range. During baseline mean anxiety scores were higher than the intervention and post-
intervention phases and within the “borderline abnormal” range. During the intervention and 
post-intervention phases the mean anxiety scores were similar and also remained within the 
“borderline abnormal” range. Due to the small sample size (n= 6) and the minimal 



































Figure 7. Mean HADS scores for depression and anxiety across all study phases for the six 
participants. The error bars represent standard error of the mean.  
An additional question was included at the bottom of the HADS form. This question 
asked ‘have you had changes to your personal circumstances, such as changes to your 
financial situation, marital status, working conditions and/or social support?’ Participants 
could respond by indicating Yes or No, and then expand if they selected Yes. This data was 
analysed and several main themes were identified. The most common theme was negative 
cancer-related medical events, with 83% of participants reporting events that negatively 
impacted on them that week, such as treatment decisions and side effects. Negative cancer-
related medical events were followed by family-related changes (67%) such as additional 
family members being diagnosed with cancer, death of an immediate family member or 
marital issues. Other reasons for changes in participant’s circumstances included non-cancer 
related stress (33%) which comprised financial issues and stress at work; medical events 
unrelated to the participant’s breast cancer (33%); and changes to social support (33%) which 
included joining various social groups such as walking and yoga, cancer support groups, 
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reported positive cancer-related medical events such as negative biopsy results. One 
participant responded that they were impacted by personal changes, however, this participant 





Chapter Four: Discussion 
The current study evaluated the effectiveness of a psychoeducational-based group 
intervention (the LW programme) on the psychological well-being of women diagnosed with 
early stage breast cancer patients in the Waikato region. It was expected that attending the 
LW programme would help inform participants about their cancer, diagnosis and treatment 
and would therefore reduce anxiety and depression scores as measured by the HADS.  
The intervention in this study did not have a consistent systematic influence on the 
HADS scores for all participants as indicated by the lack of a systematic and clinically 
significant decrease in the scores corresponding with the treatment. Mean depression scores 
across all phases (baseline, intervention, and post-intervention) were lower than anxiety 
scores for all participants and remained within the normal range (0-7), whilst mean anxiety 
scores, which were higher in baseline than intervention and post-intervention, remained in the 
borderline abnormal range (8-10) across all phases. Individual depression and anxiety scores 
were variable across all phases, thus there was no clear evidence that the LW programme was 
effective in improving well-being in the breast cancer patients who attended.  
The current study found no consistent systematic effect on well-being from attending 
the LW programme. Psychoeducational-based interventions tend to be most beneficial to 
cancer patients who have relatively few psychosocial coping resources, such as lack of 
support, lack of informational support from a medical team, or few personal resources (i.e., 
low perceived control, low self-esteem) (Helgeson et al., 2000). The level of support from 
family and friends can moderate the effectiveness of a psychoeducational-based intervention 
(Cipolletta et al., 2019; Helgeson et al., 2000). All participants in the current study reported a 
high level of social support, such as family and friends, which may explain why no changes 
were seen as a result of attending the LW programme. However, three participants did report 
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a benefit of the programme in that it provided additional avenues for social support, such as 
yoga and walking groups. Cipolletta et al. (2019) also reported that their psychoeducational 
intervention was associated with improvements in interpersonal relationships and introduced 
various opportunities for increasing social support. 
HADS scores did not differ significantly between phases in the current study, 
suggesting that there was no effect of the intervention on the well-being of the six 
participants who participated in the programme. Maeda et al. (2008) also found over a three-
session psychoeducational intervention, that their intervention was not effective for all 
fourteen participants, as indicated by HADS scores not differing between baseline, 
intervention, and post-intervention phases. Additionally, no consistent systematic effect on 
well-being over 6 months was identified. Andreis et al. (2018) also found no significant effect 
of a psychoeducational intervention on anxiety, however, there was a statistical difference 
and therefore improvement in depression scores between baseline and post-intervention. 
Chujo et al. (2005) studied the effects of a psychoeducational group intervention in women 
with recurrent breast cancer and found that although there were lower mean anxiety and 
depression scores after the intervention these were insignificant. The authors do suggest that 
these insignificant results may be due to the small sample (n=39).  
In contrast, Ram et al. (2013) and Al-Sulaiman et al. (2018) found that 
psychoeducational-based interventions improved well-being in breast cancer patients. These 
studies differed from the current study as they used different measures (WHO-5 Wellbeing 
Index and Depression, Anxiety and Stress Scale 21 item version (DASS-21) respectively) and 
the intervention phase of their studies was conducted over a much longer time period (4 
weeks and 12 weeks respectively). Furthermore, Doulbeaut et al. (2009) found a significant 
reduction in anxiety and a reduction in depression in breast cancer patients after an 8-week 
psychoeducational intervention consisting of two-hour sessions. All participants in the 
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current study only participated in a 2-week intervention (over 2 days) with a follow-up 
duration of 4-weeks, which may explain the differences seen. Additional differences between 
the study by Doulbeaut et al. (2009) and the current study were the different measures used 
and the intervention in the study by Doulbeaut et al. (2009) being based on cognitive 
behavioural therapy principles.   
Participants in the current study had consistently higher mean anxiety scores 
compared to depression before, during and post intervention. Consistent with the current 
findings, Maeda et al. (2008) and Andreis et al. (2018) also found anxiety scores measured by 
the HADS were higher than those of depression in early stage breast cancer patients. Anxiety 
typically affects between 20% to 50% of women diagnosed with breast cancer, and is more 
common than depression (Abu-Helalah et al., 2014; Bottomley, 1997; Dastan & Buzlu, 2011; 
Lim et al., 2011; Payne et al., 1999; Yi & Syrjala, 2017). Young age, having low social 
support and having a low income are risk factors of increased anxiety. In the current study, 
two participants were under the age of 50 years. Participant 6 (47 years) had higher levels of 
anxiety than depression and their anxiety levels were relatively higher (in the abnormal 
range) compared to all of the other participants. This finding is consistent with other research 
which has found that younger women with breast cancer commonly experience more 
psychological distress (Al-Sulaiman et al., 2018; Peled et al., 2008), are at increased risk of 
reporting high anxiety (Doulbeaut et al., 2009), depression (Davis et al., 2018), and are more 
likely to have a decreased quality of life and increased symptom burden than older women 
(Hamer et al., 2017).  
All participants in the current study reported having good levels of social support, so 
the high anxiety scores seen cannot be attributed to a deficit in this area. Maeda et al. (2008) 
also reported that participants who reported high levels of support demonstrated less distress, 
noting that social support may have resulted in better adaptive coping and psychological 
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state. Al-Sulaiman et al. (2018) also found that significant improvements in patient’s anxiety, 
depression and stress scores and their well-being could be attributed to social support levels. 
A systematic review and meta-analysis on the effectiveness of psychoeducational 
interventions, with breast cancer patients found that increased support from family can 
improve well-being (Matthews, Grunfeld, & Turner, 2017). In the current study one 
participant (participant 6), who had the highest anxiety scores, was separated and going 
through a divorce at the time of the study, which likely contributed to her anxiety level, as 
divorce is a significant life stressor (Sbarra, Hasselmo, & Nojopranoto, 2012). Additionally, 
three participants reported financial issues (participant 6, who had the highest levels of 
anxiety compared to the other participants, and participants 2 and 3). These participants were 
not currently in paid employment and typically had higher anxiety scores compared to their 
depression scores. Al-Sulaiman et al. (2018) also found that patients who reported financial 
difficulties tended to have high depression, anxiety and stress scores. 
In the current study participant 6 reported having physical symptoms (such as 
difficulty breathing and heart palpitations) during baseline, which led them to worry about 
cancer progression. Participant 4 reported feeling fatigue which consequently led them to 
worry about cancer recurrence. Experiencing fatigue and psychological stressors, such as fear 
concerning spread of disease, treatment-related anxiety and misinterpretation of neutral 
physical symptoms as progression or recurrence of disease is common and can exacerbate 
anxiety and anxious preoccupation (Baucom et al., 2006; Henselmans et al., 2010; Institute of 
Medicine and National Research Council, 2004; Lasry & Margolese, 1992; Lee-Jones, 
Humphris, Dixon, & Hatcher, 1997; Reich et al., 2008; Spiegel, 1997; Villar et al., 2017). 
Women diagnosed with breast cancer are also faced with a number of treatment decisions 
which can be associated with anxiety levels. Participant 6 reported having concerns regarding 
having a mastectomy without reconstruction. She felt that this decision was out of her hands 
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and was worried about the cosmetic outcome of surgery, which resulted in her seeking 
psychological support. The week that participant 6 was informed that she required a 
mastectomy was the same week where her highest anxiety score on the HADS was recorded. 
Mastectomy is an invasive procedure which is related to body image concerns and decisions 
on whether to have reconstruction and can cause worry and anxiety (Dicks et al., 2019). 
Certain breast cancer treatment can be traumatic and significantly affect body image 
(Vahdaninia et al., 2010; Villar et al., 2017), sexuality, attractiveness and femininity (Reich et 
al., 2008), which consequently exacerbates anxiety. For some societies, the female breast is 
regarded as a symbol of intrinsic femininity, maternal pleasure and sexual desire, and are 
fundamental to the image of what many people consider “being a woman”. Thus, given the 
significance society places on female breasts, any alterations or surgery may make woman 
feel less attractive, adversely affecting their self-esteem, confidence and sexuality. Participant 
1 reported feeling anxious leading up to her surgery, largely due to it being her first ever 
surgery (week 1 on Figure 1). This was reflected by her high anxiety score during the week of 
her surgery. Participant 5 was more anxious after learning that she required additional surgery 
due to cancer progression, which was also reflected in her high anxiety score at that time 
(week 5 on Figure 5). During this week, the participant’s anxiety and depression scores were 
the highest scores that the participant reported throughout the study. Villar et al. (2017) found 
that women are relieved, tend to be less anxious and appear to have a more positive outlook 
on the future once adjuvant treatments have been completed.  
 Although there is only limited research on psychoeducational interventions, they have 
been found to be helpful for breast cancer patients (Neises, 2008; Yavuzsen et al., 2012). In 
the current study, participant 6 reported that the group format provided them with “more 
avenues for social support and consequently joined a walking group and yoga”, and the 
programme had been beneficial and had allowed them the opportunity to meet others on 
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“similar cancer journeys”. Cipolletta et al. (2019) also found that participants reported that 
the group format of the intervention provided them the opportunity to develop new social 
relationships which alleviated the sense of loneliness and isolation. Group formatted 
interventions can provide opportunities for effective support concerning the impact of cancer; 
increase of personal resources; provide a safe space for the expression of emotion; and the 
sharing and exchange of experiences, emotions and information regarding the illness and 
everyday life (Cameron et al., 2007; Ussher, Kirsten, Butow, and Sandoval, 2008). Cipolletta 
et al. (2019) found that the group structure of the psychoeducational intervention was useful 
for breast cancer patients by providing a network which allowed participants the opportunity 
to exchange knowledge regarding cancer, accept changes, develop new social ties, and be less 
dependent on medical staff.  
In the current study however, participant’s 1 and 6 decided not to attend two 
workshops (Advance Care Plan and Cancer and Uncertainty), which were in the second 
session of the LW programme. Both participants reported that they did not want to be 
surrounded with others who had cancer or who were medically worse than they were, nor did 
they want the LW programme to be detrimental to their current positive outlook. 
Furthermore, after the completion of the LW programme participant 1 reported that they felt 
“down and depressed” due to too much confrontation of seeing others who were in similar 
situations or more unwell than they were. In contrast, Cipolletta et al. (2019) reported that a 
group situation is not intended to be depressive but rather a space where the expression of 
anxiety and worries is encouraged and by listening to other participant’s experiences patients 
can improve and develop their coping strategies and discover prospects for improvement. 
Furthermore, the authors note that the group psychoeducational intervention endorsed 
altruism, which is a critical experience as it allows members to identify with each other and 
possibly feel useful to other members who are suffering in a similar manner.  
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Other research suggests that there can be difficulties with the group aspect of 
psychoeducational interventions, and that they are often recognised by patients as only 
necessary for those who are in substantial need or distress (Ussher et al., 2008). In a 
qualitative analysis investigating reasons for attending or not attending group interventions 
and support groups, it was found that group formats were commonly identified by cancer 
patients as negative places surrounded by sick people where negative stories were exchanged, 
other people’s issues would become a burden, and death would be discussed, thus having a 
detrimental effect on patient’s well-being and influencing them to avoid the group (Ussher et 
al., 2008). Helgeson et al. (2000) state that members participating in group interventions may 
not always behave in supportive ways and group situations can make participants feel 
uncomfortable. Breast cancer patients have reported being distressed by making social 
comparisons in group situations, such as feeling anxious about one’s own illness when faced 
with someone worse-off (Helgeson et al., 2001). However, this did not appear to be a factor 
for Al-Sulaiman et al. (2018), Cipolletta et al. (2019), Doulbeaut et al. (2009), or Maeda et al. 
(2008). Thus, the variable results in the current study suggest that group interventions, 
including psychoeducational interventions, may not always be advantageous or the most 
suitable means of support and education for every individual due to individual differences. 
Therefore, it is critical that cancer patients and their support systems are made aware of 
alternative avenues of support and education, such as CPSSS and individual counselling, and 
attention should be given to exposing the positive experiences that can occur within group 
interventions in order to challenge common misunderstandings. 
Strengths and Limitations 
The current study used a repeated measures design which involved multiple 
measurements. Participants were exposed to all treatment conditions (the LW programme). 
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With participants being effectively compared against themselves, there is no risk of 
individual differences impacting the results. 
A major limitation of the current study was that repeated measurement in a baseline 
will not control for history effects that appear between the last baseline measurement and the 
first intervention measurement (Engel & Schutt, 2008). The longer the duration between the 
two measurement points, the more likely it is that an event may influence the participant’s 
scores threatening validity. Thus, a multiple baseline design would have been ideal to control 
for history effects. In a multiple baseline design the time that the intervention starts is 
staggered across participants, each change from baseline to treatments is a chance to observe 
the effects of the intervention, thus making this change at various times allows the researcher 
to disregard alternative explanations for any behaviour change that occurs during treatment 
(Morgan & Morgan, 2009). Therefore, if a participant’s behaviour is stable during baseline 
and changes only when the intervention occurs, it can be confidently concluded that the 
change occurred from the treatment and not from some uncontrolled variable. As the LW 
programme is a group intervention and due to time and practical constraints the programme 
could not realistically be offered multiple times in close succession by the Cancer Society, 
thus all participants were exposed to the LW programme at the same time.  
The short time frame of the LW programme as well as additional confounding 
variables (significant personal events participants were experiencing) were unable to be 
controlled for and so may have influenced the results of the study. The fact that some 
participants completed the HADS via telephone and other participants completed the HADS 
face-to-face with the researcher may have impacted the results in that some participants who 
answered face-to-face may have provided answers that they deemed socially desirable or may 
have been less open. Moreover, the sole measure (the HADS) utilised in this study relied on a 
self-report format which may have been subject to socially desirable responses leading to 
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lower scores. Other limitations include the homogenous characteristics of participants. 
Participants were a similar ethnicity, predominantly NZ European, thus, unfortunately there 
was no representation of participants who identified as Māori or Pacific Peoples. However, 
ethnicity was not intended as the chosen focus for the current study. The needs of minority 
populations have rarely been investigated, particularly in NZ, thus, it would be of interest to 
extend this study to investigate the impact of psychosocial cancer-related distress on different 
ethnic groups, other populations such as men, and participants under the age of 40. Studying 
other cancer types and later stage cancers is also important to gain a broader understanding of 
the LW programme and the support in NZ of diverse groups affected by cancer. Given the 
limitations imposed by the small sample size, it would be beneficial to develop a larger 
quantitative study which could potentially add to the literature by creating a multi-location 
study capable of obtaining larger numbers of participants.  
Psychoeducational interventions which are brief in session and duration can still have 
a substantial impact on a variety of patient variables such as quality of life and well-being. 
Although what constitutes ‘brief psychoeducation’ can differ, a systematic review found that 
the median length of psychoeducation is typically 12 weeks (Xia, Merinder, & Belgamwar, 
2011). A study by Scheier et al. (2005) was successful in enhancing physical and 
psychological functioning among breast cancer patients in only four psychoeducation 
sessions for a duration of two hours each. There is evidence to suggest that moderately short, 
but intensive, interventions, delivered by experienced and trained professionals are more 
effective than more prolonged and drawn out interventions or interventions offered by staff 
that are not adequately trained (Sheard & Maguire, 1999). However, more sessions of the LW 
programme would allow for more data, allow for a greater number of participant concerns to 
be addressed, and may produce greater changes in anxiety and depression scores. The current 
study only followed participants over a short period of 4-weeks after the intervention, thus 
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little is known about participant’s well-being over the longer term. Although short-lived 
effects of psychoeducational interventions are critical, specifically if they occur during times 
of marked distress, it would be of interest to administer a 6-month and 3-year follow-up post 
the LW programme to further investigate participant’s well-being. Additionally, the one-
week interval between the first session of the LW programme and the second session of the 
LW programme may have been too short for participants to take in the information delivered 
at the first LW session, feel more informed and comfortable, and for anxiety and depression 
to reduce. Thus, future research could obtain data over a longer course of time post-
intervention and the second session of the LW programme could be delivered after a longer 
interval. It should also be noted that not all participants attended the full two day LW 
programme. Two participants did not attend two of the workshops on the second session of 
the LW programme which may have consequently impacted results as there was less data 
(HADS scores) collected. Furthermore, the LW programme was not designed for a specific 
cancer type, therefore participants in the current study may have been better suited to a 
programme specifically designed for breast cancer patients and their concerns. It is unknown 
whether the breast cancer intervention (Look Good Feel Better) was advertised to the 
participants in the current study. 
Not all psychoeducation content is the same, therefore, developing an effective 
psychoeducation programme can be challenging. Furthermore, the differences in outcomes 
between studies could be due to differences in specific components of the psychoeducational 
programmes that are utilised. A component analysis, which is a systematic analysis of 
independent variables that comprise a treatment/intervention (Baer et al., 1968; Cooper, 
Heron, & Heward, 2007), can enhance the effectiveness of behavioural interventions and 
allow for the identification of active and necessary components in an intervention and the 
relative contributions of various variables in an intervention which are responsible for 
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behaviour change (Ward-Horner & Sturmey, 2010). The component analysis involves 
repeated measures design with the components being systematically introduced and/or 
withdrawn, in addition to the replication of effects within and/or between subjects (Dallery, 
Riley, & Nahum-Shani, 2015). A component analysis was not conducted with the LW 
programme but would have likely been beneficial and helped to improve the overall 
effectiveness of the LW programme.  
Implications 
The findings in this study have practical applications for organisations such as the 
Cancer Society and can be used to inform such organisations of the effectiveness of 
intervention based programmes. While no clear effect of attending the LW programme was 
demonstrated, there is still a clear need to address psychosocial distress concerning a breast 
cancer diagnosis. Interventions may be more effective if they involve more sessions and 
patients need to be informed regarding other avenues for psychosocial cancer-related support 
such as the free service provided by the CPSSS which caters to a more individual rather than 
group format.  
Conclusion 
The aim of the current study was to assess the effects of the LW programme on the 
psychological well-being of early stage breast cancer patients in the Waikato region. No 
effect of attending the LW programme was found for this group of participants, as 
demonstrated by no consistent decrease in HADS scores during and post attending the 
programme. Across all phases of the study, mean depression scores were lower than mean 
anxiety scores. Mean anxiety scores were only slightly higher in baseline compared with 
mean anxiety scores during the intervention and post-intervention. The results of this study 
suggest that the LW programme had no consistent effect on well-being for this group of 
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participants, however, psychosocial distress in the breast cancer patients recruited for the 
study was evident, and reflected in the HADS scores obtained. There is a need for 
psychosocial interventions to address the psychosocial needs of cancer patients, and to 
provide information to better inform, help develop improved coping strategies, and develop 
new avenues of social support. While limitations impacted the findings of this study, the 
results contribute to future research regarding the psychological support of breast cancer 
patients and their families in NZ. Continuing research is needed to support the psychological 
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Gender (circle one): 
Female   Male 
 
Date of birth: 
 
What area do you live in (circle one):  
Urban  Rural 
 
Ethnicity (circle one): 
New Zealand European Maori  Samoan Cook Island Maori 
Tongan   Chinese Indian  Other (please specify):  
 




Have you had a previous cancer diagnosis? (circle one): 
Yes  No 
If yes, are you able to provide details of the type and stage: 
Stage on cancer continuum (circle one): 
Diagnosis  Treatment  Post-Treatment  Recurrence 
 
Date of referral to the Cancer Society: 
 
 
Who referred you to the Cancer Society (circle one): 
General Practitioner (GP)  Cancer Nurse Specialist (CNS)   
Self-Referred    Other (please specify):   
 
Have you ever received psychological, psychiatric or counselling services 
since your diagnosis? (circle one):  
Yes  No 
 
Have you participated in any previous Cancer Society groups/programs? 
(circle one): 
Yes  No 
If Yes, please specify the below: 
Name of Programme(s):  
    




Do you have family/social support? (circle one): 
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Yes  No 
 
Marital status (circle one): 
Single    Married, in a Civil Union, or in a De Facto Relationship 
Divorced   Separated    Other:   
 
Employment status (circle one): 
Full-time employed   Part-time employed  On leave but still employed 
Unemployed   Unemployed and looking for work Studying 
Retired   Other: 
 
What, if any, resources have you accessed in regard to your cancer since 
diagnosis (circle one): 
Internet    Social Media (i.e. Facebook)   
Pamphlets     Other (please specify): 
 
Are you able to meet the researcher once a week for 4-6 weeks BEFORE 
and AFTER the Living Well Programme to complete a questionnaire 
(circle one)? 
Yes   No 
If yes, please circle what day and time, and specify what location (e.g., café, 
your house) would be suitable?  
Monday Tuesday Wednesday Thursday Friday   Saturday Sunday 
Morning (between 9-12) Afternoon (1-4) Night (6-8) 
Location: 
 
If no, what day and time would be suitable for the researcher to contact 
you each week via phone to complete the questionnaire? (circle one): 
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Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
 
Morning (between 9-12) Afternoon (1-4) Night (6-8) 
 
 





Participant Information Sheet 
 
Study title: Evaluating the effectiveness of an Education Group Intervention on the 
psychological wellbeing of breast cancer patients 
 
Lead investigator: Brittany Ryan, University of Waikato 
 
 
You are invited to take part in a study where we are planning to evaluate the effectiveness of 
an education-based intervention on your psychological wellbeing. This project will be 
conducted by a master’s student from the School of Psychology at the University of Waikato. 
Whether or not you take part is voluntary. If you do not wish to take part, you do not have to 
give a reason. If you do want to take part now, but change your mind later, you can withdraw 
from the study at any time. Please read this information sheet carefully before deciding whether 
you wish to participate.  
 
This Participant Information Sheet will help you decide if you would like to take part.  It 
explains why we are doing the study, what your participation would involve, what the benefits 
and risks to you might be, and what would happen after the study ends.   
If you consent to participating we will go through this information with you and answer any 
questions you may have. You do not have to decide today whether or not you will participate 
in this study. Before you decide you may want to talk about the study with other people, such 
as family, whānau, friends, or healthcare providers.  Please feel free to do this. 
 
If you agree to take part in this study, you will be asked to sign the Consent Form on the last 
page of this document.  You will be given a copy of both the Participant Information Sheet and 
the Consent Form to keep. 
 
This document is nine pages long, including the Consent Form and a Patient Questionnaire 
sheet. Please make sure you have read and understood all the pages.   
 
What is the purpose of the study? 
Providing education and social supports to people affected by cancer can improve mood and 
psychological wellbeing. Little is known about the impact of education approaches on the 
psychological wellbeing of cancer patients, particularly in New Zealand Therefore, the primary 
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aim of this study is to evaluate the effectiveness of an education-based intervention on the 
psychological wellbeing of breast cancer patients. We are aiming to recruit between 4-12 
people for the study, and the outcomes of this study will help us to better understand the effects 
of an education-based intervention on the psychological wellbeing of people diagnosed with 
breast cancer in New Zealand.  
What will my participation in the study involve? 
To participate in this study, you must be over the age of 18 years, have been recently 
referred/self-referred to the Cancer Society of New Zealand, diagnosed with stage 1 or 2 breast 
cancer, and not have previously attended the Living Well Programme run by the Cancer Society. 
You should also not currently be involved in any other Cancer Society support group.   
You will have been referred to the Cancer Society and as per their protocol will have received 
a home visit by a Cancer Society nurse. During this visit, if you consented to your contact 
details being passed on to the master’s student, you would have received this patient 
information sheet and consent form. As you have consented to your contact details being passed 
on to the researcher you will consequently receive a phone call from the researcher to arrange 
a face-to-face meeting where you will receive additional information regarding the study, have 
time to ask any questions you may have and the researcher will go over this patient information 
sheet and the consent form more thoroughly with you. You are welcome to have support people 
at this meeting with the researcher if you choose. It is important for you to note that whether 
you to decide to participate in this study or not, the level of care that you receive from the 
Cancer Society or any other health professional will not be affected.  
If you agree to participate, the researcher will arrange with you a weekly meeting at an agreed 
upon location and time where you will be asked to complete one questionnaire each week. This 
will occur for 4-6 weeks BEFORE the Living Well Programme begins. This questionnaire will 
take 5-10 minutes to complete.  
After the 4-6 weeks of completing the questionnaires, you will be invited to participate in the 
Living Well Programme. This consists of two 4-5 hour education sessions occurring over a 
two 2 week period (i.e. 5 hour session one week and another 5 hour session the following week. 
The two-day programme offers practical ways of living well, building knowledge, self-
confidence, and self-help skills to cancer patients of any stage and type. The programme will 
be run by specially trained liaison nurses with expert speakers from a variety of backgrounds 
and professions. Topics included in the programme will cover understanding cancer, managing 
the side-effects of cancer treatment, nutrition, self-care, relaxation and stress management, and 
communication. The Living Well Programme will take place at the Cancer Society Lodge, 
situated in central Hamilton with plenty of parking available. After both sessions, you will be 
asked to please complete the same questionnaire (which you completed for 4-6 weeks 
previously). 
After the Living Well Programme has finished, we would appreciate if you would meet the 
researcher each week at the same location (that you meet the researcher before the programme) 
for another 4-6 weeks where you will complete the same questionnaire (taking 5-10 minutes to 
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complete). Thus, you will be asked to complete the questionnaire a total of 10-12 times 
throughout the study.  
However, if you are unable to meet with the researcher each week alternatively the researcher 
can contact you via the phone each week, where the researcher will administer the 
questionnaire over the phone. This phone call will occur for 4-6 weeks BEFORE the Living 
Well Programme, after BOTH of the Living Well Sessions, and 4-6 weeks AFTER the Living 
Well Programme has ended. Each phone call should take 5-10 minutes.  
Data will be stored electronically in password protected files at the university.  
Total time of the study is expected to be approximately 10-12 weeks (from the initial 
questionnaires until the final questionnaires).  
What are the possible benefits and risks of this study? 
We hope that this study will allow researchers to gain a better understanding of effective 
forms of social support for breast cancer patients in New Zealand, and that this data can then 
be used to evaluate the effect of an education intervention on psychological wellbeing in breast 
cancer patients and inform later studies. 
What are my rights? 
Participation is entirely voluntary and whether you choose to participate or not will not affect 
the medical treatment you receive. If you do sign the consent form, then later change your mind, 
please let the researcher(s) know and we will remove you from the study. You may withdraw 
from the study at any time (please contact the researcher, the study’s supervisor or the Cancer 
Society Nurse, whose details are all listed at the end of this information sheet).  
You have the right to see and, if necessary, correct the information held about you. Information 
will be held either in your clinical / medical records or in a locked, password protected file on 
the researcher’s computer.  
Confidentiality is ensured, as all data from the study will be kept strictly confidential in a 
locked file/computer at the University of Waikato. No one other than those involved in the 
study will have access to this information without your permission. No information that could 
personally identify you will be used in any reports on the study. 
What happens after the study or if I change my mind? 
Participants will be provided with their individual surveys and on completion of the study a 
summary of the research findings.  
Who do I contact for more information or if I have concerns? 
If you have any questions, concerns or complaints after reading this information sheet or about 




Brittany Ryan, Master’s student, Chief Investigator in the study 
 School of Psychology, University of Waikato 
 Phone: 0277574365 
 Email: brittryan_94@hotmail.com 
 
Tim Edwards, Study’s Supervisor  
School of Psychology, University of Waikato 
 Phone: 07 837 9409 
Email: tim.edwards@waikato.ac.nz 
 
Kay Taylor, Cancer Society Nurse 
 Cancer Society of New Zealand 
 Phone: 07 9035809 
 Email: kaytaylor@cancersociety.org.nz 
 
If you want to talk to someone who isn’t involved with the study, you can contact an 
independent health and disability advocate on: 
 
Phone:  0800 555 050 
Fax:   0800 2 SUPPORT (0800 2787 7678) 
Email:  advocacy@advocacy.org.nz 
 
This research project has been approved by the Human Research Ethics Committee (Health) of the 
University of Waikato under HREC(Health)2019#43. Any questions about the ethical conduct of this 
research may be addressed to the Secretary of the Committee, email humanethics@waikato.ac.nz, 






Appendix C  
CONSENT FORM:      Evaluating the effectiveness of an Education Group Intervention on 
the psychological wellbeing of breast cancer patients 
 
Please tick to indicate you consent to the following: 
 
I have read, or have had read to me in a language of my choice, and 
I understand the Participant Information Sheet.   
Yes  No  
I have been given sufficient time to consider whether or not to 
participate in this study. 
Yes  No  
I have had the opportunity to use a legal representative, whānau / 
family support, or a friend to help me ask questions and understand 
the study. 
Yes  No  
I am satisfied with the answers I have been given regarding the 
study. I have a copy of this consent form and information sheet. 
Yes  No  
I understand that taking part in this study is voluntary (my choice) 
and that I may withdraw from the study at any time without this 
affecting my medical care. 
Yes  No  
I consent to the research staff collecting and processing my 
information 
Yes  No  
I understand that my participation in this study is confidential and 
that no material which could identify me personally will be used in 
any reports on this study. 
Yes  No  










I know who to contact if I have any questions about the study in 
general. 
Yes  No  






Declaration by participant: 












Declaration by member of research team: 
 
I have given a verbal explanation of the research project to the participant and have answered 
the participant’s questions about it.   
 
I believe that the participant understands the study and has given informed consent to 
participate. 
 
Researcher’s name: 
 
 
 Date: 
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Signature: 
 
 
 
 
